Tenax Issuance Of Capital Stock from 2010 to 2025

TENX Stock  USD 5.97  0.04  0.67%   
Tenax Therapeutics Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock will likely drop to about 7.9 M in 2025. During the period from 2010 to 2025, Tenax Therapeutics Issuance Of Capital Stock regression line of annual values had r-squared of  0.0007 and arithmetic mean of  8,565,476. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
10.6 M
Current Value
7.9 M
Quarterly Volatility
1.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 K, Other Operating Expenses of 8.4 M or Research Development of 3.6 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 0.64. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of Tenax Therapeutics over the last few years. It is Tenax Therapeutics' Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Very volatile
   Issuance Of Capital Stock   
       Timeline  

Tenax Issuance Of Capital Stock Regression Statistics

Arithmetic Mean8,565,476
Geometric Mean8,208,283
Coefficient Of Variation20.90
Mean Deviation882,060
Median8,907,174
Standard Deviation1,790,059
Sample Variance3.2T
Range8.4M
R-Value(0.03)
Mean Square Error3.4T
R-Squared0.0007
Significance0.92
Slope(9,807)
Total Sum of Squares48.1T

Tenax Issuance Of Capital Stock History

20257.9 M
202410.6 M
20219.2 M
20208.7 M
20192.1 M

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock10.6 M7.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.